|
Online Database of Chemicals from Around the World | Search | Submit | Advertise |
Home >> Chemical Listing >> PCI-32765>> Market Analysis Reports |
Market Analysis Reports of PCI-32765 |
|
CAS 936563-96-1 PCI-32765 Chemical Report & Database CAS 936563-96-1 PCI-32765 Chemical Report & Database This PCI-32765 Chemical World Consumption Report & Database ... sector. The PCI-32765 World Consumption Report & Database definitions: Name: PCI-32765: PCI-32765; 1-[(3R)-3-[4-Amino-3-(4-phenoxyphenyl ... Pharmacyclics Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... Bruton's tyrosine kinase (Btk) (PCI-32765) in a Phase I clinical trial targeting oncology ... indications for an anticipated IND. PCI-32765 for Oncology The company ... lymphoma in dogs. It initiated a trial of PCI-32765 in spontaneous canine lymphoma in companion ... PHARMACYCLICS - Ibrutinib - Promising to Deliver More ... PhIII data and approval of Ibrutinib (PCI-32765, PhIII, BTK inhibitor, partnered with ... Pharmacyclics – Ibrutinib: A Game Changer – 3 Breakthrough Therapy Designations + More Data ASCO/EHA ‘13 ASCO ‘13 abstracts highlight Ibrutinib (PCI-32765, PhIII, BTK inhibitor, partnered with ... |